Results of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: Results of a randomised Phase 2 study... von Richards, Donald, Kocs, Darren M, Spira, Alexander I, David McCollum, A, Diab, Sami, Hecker, Lanny I, Cohn, Allen, Zhan, Feng, Asmar, Lina

Volltext

Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-Line Treatment of Patients with Stage IIIB/IV Non-sma... von Socinski, Mark A., Raju, Robert N., Stinchcombe, Thomas, Kocs, Darren M., Couch, Linda S., Barrera, David, Rousey, Steven R., Choksi, Janak K., Jotte, Robert, Patt, Debra A., Periman, Phillip O., Schlossberg, Howard R., Weissman, Charles H., Wang, Yunfei, Asmar, Lina, Pritchard, Sharon, Bromund, Jane, Peng, Guangbin, Treat, Joseph, Obasaju, Coleman K.

Volltext

Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive... von Holmes, Frankie Ann, Hellerstedt, Beth A., Pippen, John E., Vukelja, Svetislava J., Collea, Rufus P., Kocs, Darren M., Blum, Joanne L., McIntyre, Kristi J., Barve, Minal A., Brooks, Barry D., Osborne, Cynthia R., Wang, Yunfei, Asmar, Lina, O'Shaughnessy, Joyce

Volltext

Efficacy of milciclib (PHA-848125AC), a pan-cyclin d-dependent kinase inhibitor, in two phase II studies with thymic carcinoma (TC) and B3 thymoma (B3T) patients von Besse, Benjamin, Garassino, Marina Chiara, Rajan, Arun, Novello, Silvia, Mazieres, Julien, Weiss, Glen J., Kocs, Darren M., Barnett, John Mark, Davite, Cristina, Crivori, Patrizia, Giaccone, Giuseppe

Volltext

Volume and Outcome von Barone, James E, Risucci, Donald A, Savino, John A

Volltext

Randomized phase II trial of preoperative chemoradiotherapy with or without cetuximab in locally advanced rectal adenocarcinoma von McCollum, A. David, Kocs, Darren M., Chadha, Punit, Monticelli, Michael A., Boyd, Thomas E., Fain, Jerry Dean, Kasper, Michael, Sanchez, James, Simon, Miklos, Singh, Paramjeet, Thummala, Anu, Vukelja, Svetislava J., Wang, Yunfei, Asmar, Lina, Richards, Donald A.

Volltext

Final analysis of phase II study of EZN-2208 (PEG-SN38) in metastatic breast cancer (MBC) von Osborne, Cynthia R. C., O'Shaughnessy, Joyce, Holmes, Frankie Ann, Kim, Hyun Sue, Kocs, Darren M., Steinberg, Michael S., Richards, Paul D., Vukelja, Svetislava J., Berkowitz, Noah C., Buchbinder, Aby

Volltext

Phase II study of gemcitabine, cisplatin, and sunitinib (S) in patients with advanced urothelial carcinoma (UC) von Galsky, Matt D., Hellerstedt, Beth A., O'Rourke, Mark Allen, Vogelzang, Nicholas J., Kocs, Darren M., McKenney, Scott A., Melnyk, Anton M., Hutson, Thomas E., Rauch, Mary Ann, Wang, Yunfei, Asmar, Lina, Sonpavde, Guru

Volltext

Volume and outcome von Kocs, Darren M

Volltext

Gemcitabine, Cisplatin, and Sunitinib for Metastatic Urothelial Carcinoma and as Preoperative Therapy for Muscle-Invasive Bladder Cancer von Galsky, Matthew D, Hahn, Noah M, Powles, Thomas, Hellerstedt, Beth A, Lerner, Seth P, Gardner, Thomas A, Yu, Menggang, O'Rourke, Mark, Vogelzang, Nicholas J, Kocs, Darren, McKenney, Scott A, Melnyk, Anton M, Hutson, Thomas E, Rauch, Mary, Wang, Yunfei, Asmar, Lina, Sonpavde, Guru

Volltext

Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience von Kocs, Darren, Fendrick, A Mark

Volltext